Swedish Melanoma Detection Device To Be Piloted at Dallas-Area Bare Dermatology Clinics
Source: Dallas Innovates, September 2023
Doctors can often identify signs of a melanoma through a visual examination of a patient’s skin, by using a dermoscope or other tools. But additional information is sometimes needed to make a precise diagnosis, according to SciBase, a medical tech company based in Stockholm, Sweden—which has developed a device it says provides exactly that.
The device, called Nevisense, uses small electrical impulses to detect cellular irregularities beneath the skin’s surface. SciBase says the method has been proven “in the world’s largest melanoma detection study of its kind,” and is “the only FDA-approved test for early melanoma detection at point-of-care.”
Today SciBase announced that it’s partnering with North Texas-based Bare Dermatology—which has five offices in the Dallas area—to pilot the device at select locations. Headquartered in Aubrey north of Dallas-Fort Worth, Bare Dermatology was founded in 2022.